Page 45 - Read Online
P. 45
on second-line Fotemustine chemotherapy in recurrent 10. Addeo R, Caraglia M, De Santi MS, Montella L,
glioblastoma. J Neurooncol 2009;92:79-86. Abbruzzese A, Parlato C, Vincenzi B, Carraturo M, Faiola V,
6. Soffi etti R, Trevisan E, Bertero L, Cassoni P, Morra I, Genovese M, Cennamo G, Del Prete S. A new schedule of
Fabrini MG, Pasqualetti F, Lolli I, Castiglione A, Ciccone G, fotemustine in temozolomide-pretreated patients with relapsing
Rudà R. Bevacizumab and fotemustine for recurrent glioblastoma. J Neurooncol 2011;102:417-24.
glioblastoma: a phase II study of AINO (Italian Association of 11. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D,
Neuro-Oncology). J Neurooncol 2014;116:533-41. Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R,
7. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Bevacizumab
Sorensen AG, Galanis E, DeGroot J, Wick M, Gilbert MR, alone and in combination with irinotecan in recurrent
Lassman AB, Tsien C, Mikkelsen T, Wong ET, glioblastoma. J Clin Oncol 2009;27:4733-40.
Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, 12. Reardon DA, Herndon JE 2nd, Peters K, Desjardins A, Coan A,
van der Bent MJ, Chang SM. Updated response assessment Lou E, Sumrall A, Turner S, Sathornsumetee S, Rich JN,
criteria for high-grade gliomas: response assessment in Boulton S, Lipp ES, Friedman HS, Vredenburgh JJ. Outcome
neuro-oncology working group. J Clin Oncol 2010;28:1963-72. after bevacizumab clinical trial therapy among recurrent grade III
8. Silvani A, Lamperti E, Gaviani P, Eoli M, Fiumani A, malignant glioma patients. J Neurooncol 2012;107:213-21.
Salmaggi A, Falcone C, Filippini G, Botturi A, Boiardi A.
Salvage chemotherapy with procarbazine and fotemustine How to cite this article: Calvo OF, López MEP, Gómez JG. Complete
combination in the treatment of temozolomide treated response with fotemustine and bevacizumab after early progression
recurrent glioblastoma patients. J Neurooncol 2008;87:143-51. following radiotherapy and temozolomide treatment in patient with
9. Gaviani P, Salmaggi A, Silvani A. Combined chemotherapy glioblastoma multiforme. J Cancer Metastasis Treat 2015;1:36-8.
with temozolomide and fotemustine in recurrent glioblastoma Received: 24-10-2014; Accepted: 23-02-2015.
patients. J Neurooncol 2011;104:617-8. Source of Support: Nil, Confl ict of Interest: None declared.
38 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 1 ¦ April 15, 2015 ¦